3 Mid-Cap Stocks That Fall Short

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

DOCU Cover Image

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here are three mid-cap stocks to pass on and some alternatives you should look into instead.

DocuSign (DOCU)

Market Cap: $10.53 billion

Creating the digital equivalent of "sign on the dotted line" for over a billion users worldwide, DocuSign (NASDAQ: DOCU) provides an agreement management platform that enables businesses to electronically prepare, sign, and manage documents and contracts.

Why Do We Avoid DOCU?

  1. Underwhelming ARR growth of 8.5% over the last year suggests the company faced challenges in acquiring and retaining long-term customers
  2. Extended payback periods on sales investments suggest the company’s platform isn’t resonating enough to drive efficient sales conversions
  3. Operating profits and efficiency rose over the last year as it benefited from some fixed cost leverage

At $55.41 per share, DocuSign trades at 3x forward price-to-sales. Check out our free in-depth research report to learn more about why DOCU doesn’t pass our bar.

Bio-Techne (TECH)

Market Cap: $11.24 billion

With a catalog of hundreds of thousands of specialized biological products used in laboratories worldwide, Bio-Techne (NASDAQ: TECH) develops and manufactures specialized reagents, instruments, and services that help researchers study biological processes and enable diagnostic testing and cell therapy development.

Why Are We Out on TECH?

  1. Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
  2. Subscale operations are evident in its revenue base of $1.21 billion, meaning it has fewer distribution channels than its larger rivals
  3. Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results

Bio-Techne is trading at $72.42 per share, or 36x forward P/E. To fully understand why you should be careful with TECH, check out our full research report (it’s free).

Old Republic International (ORI)

Market Cap: $10.37 billion

Founded during the Roaring Twenties in 1923 and weathering nearly a century of economic cycles, Old Republic International (NYSE: ORI) is a diversified insurance holding company that provides property, liability, title, and mortgage guaranty insurance through its various subsidiaries.

Why Do We Think ORI Will Underperform?

  1. Sales trends were unexciting over the last five years as its 1.6% annual growth was below the typical insurance company
  2. Sluggish 2.7% annualized growth in net premiums earned over the last five years indicates the firm trailed its insurance peers
  3. Annual earnings per share growth of 2.1% underperformed its revenue over the last two years, showing its incremental sales were less profitable

Old Republic International’s stock price of $43.40 implies a valuation ratio of 1.7x forward P/B. If you’re considering ORI for your portfolio, see our FREE research report to learn more.

Stocks We Like More

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  284.02
+0.00 (0.00%)
AAPL  303.42
+0.00 (0.00%)
AMD  484.64
+0.00 (0.00%)
BAC  62.48
+0.00 (0.00%)
GOOG  372.47
+0.00 (0.00%)
META  590.24
+0.00 (0.00%)
MSFT  487.65
+0.00 (0.00%)
NVDA  206.64
+0.00 (0.00%)
ORCL  141.85
+0.00 (0.00%)
TSLA  322.08
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.